Practica Oto-Rhino-Laryngologica
Online ISSN : 1884-4545
Print ISSN : 0032-6313
ISSN-L : 0032-6313
Clinical Efficacy of Cefmenoxime (CMX) Otic Solution
Rinya SugitaShozo KawamuraYutaka FujimakiMikio TanakaHiroshi WatanabeMasashi WadaKeiji HirotaKoichi Deguchi
Author information
JOURNAL FREE ACCESS

1983 Volume 76 Issue 11 Pages 3007-3014

Details
Abstract

CMX Otic Solution, an antibiotic preparation developed for topical application, was tested for its clinical efficacy and antibacterial activity in patients with external otitis and chronic otitis media. 1% CMX or 0.5% CMX, the pH of which was adjusted to 6.5, was applied to the external auditory meatus or tympanum for 10 minutes, twice a day.
The effectiveness rate of 1% CMX was 88.2% and that of 0.5% CMX was 65.4%. In 94.1% of patients receiving 1% CMX and in 65.4% of those receiving 0.5% CMX culture became negative. 1% CMX was significantly superior to 0.5% CMX against Staphylococcus aureus and Pseudomonas aeruginosa. No serious side effects were observed. When 1% CMX was applied to the tympanum, the concentration of CMX in the serum 30 minutes later was 0.0125-0.02μg/ml.
Topical 1% CMX Otic Solution is effective in the treatment of chronic otitis media and external otitis. Patients should be tested for hypersensitivity before administration of this preparation.

Content from these authors
© The Society of Practical Otolaryngology
Previous article Next article
feedback
Top